首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo
【24h】

Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo

机译:人类血小板生成素敲入小鼠在体内有效支持人类造血功能

获取原文
获取原文并翻译 | 示例
       

摘要

Hematopoietic stem cells (HSCs) both self-renew and give rise to all blood cells for the lifetime of an individual. Xenogeneic mouse models are broadly used to study human hematopoietic stem and progenitor cell biology in vivo. However, maintenance, differentiation, and function of human hematopoietic cells are suboptimal in these hosts. Thrombopoietin (TPO) has been demonstrated as a crucial cytokine supporting maintenance and self-renewal of HSCs. We generated RAG2~(-/-)γ_c~(-/-) mice in which we replaced the gene encoding mouse TPO by its human homolog. Homozy-gous humanization of TPO led to increased levels of human en-graftment in the bone marrow of the hosts, and multilineage differentiation of hematopoietic cells was improved, with an increased ratio of myelomonocytic verus lymphoid lineages. Moreover, maintenance of human stem and progenitor cells was improved, as demonstrated by serial transplantation. Therefore, RAG2~(-/-)γ_c~(-/-) TPO-humanized mice represent a useful model to study human hematopoiesis in vivo.
机译:造血干细胞(HSC)会自我更新并在个体的一生中产生所有血细胞。异种小鼠模型被广泛用于体内研究人类造血干和祖细胞的生物学。但是,人类造血细胞的维持,分化和功能在这些宿主中次优。血小板生成素(TPO)已被证明是支持HSC维持和自我更新的重要细胞因子。我们生成了RAG2〜(-/-)γ_c〜(-/-)小鼠,在其中我们用其人类同源物替换了编码小鼠TPO的基因。 TPO的纯合人源化导致宿主骨髓中人类移植物水平提高,造血细胞的多谱系分化得到改善,骨髓单核维纳斯淋巴样谱系比例增加。此外,通过系列移植证明,人类干细胞和祖细胞的维护得到改善。因此,RAG2〜(-/-)γ_c〜(-/-)TPO-人源化小鼠代表了一种在体内研究人类造血作用的有用模型。

著录项

  • 来源
  • 作者单位

    Department of Immunobiology and, Yale University School of Medicine, New Haven, CT 06520,Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520;

    Department of Immunobiology and, Yale University School of Medicine, New Haven, CT 06520,Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520;

    Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520,Division of Hematology, University Hospital Zurich, 8091 Zurich, Switzerland,lnstitute for Research in Biomedicine, 6500 Bellinzona, Switzerland;

    Department of Immunobiology and, Yale University School of Medicine, New Haven, CT 06520,Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520;

    Regeneron Pharmaceuticals, Inc.,Tarrytown, NY 10591;

    Regeneron Pharmaceuticals, Inc.,Tarrytown, NY 10591;

    Regeneron Pharmaceuticals, Inc.,Tarrytown, NY 10591;

    Regeneron Pharmaceuticals, Inc.,Tarrytown, NY 10591;

    Department of Immunobiology and, Yale University School of Medicine, New Haven, CT 06520,Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520,Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520;

    AnaptysBio, Inc., San Diego, CA 92121;

    Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520,Division of Hematology, University Hospital Zurich, 8091 Zurich, Switzerland,lnstitute for Research in Biomedicine, 6500 Bellinzona, Switzerland;

    Department of Immunobiology and, Yale University School of Medicine, New Haven, CT 06520,Bill and Melinda Gates Foundation Grand Challenges in Global Health GC#4 Consortia, Yale University School of Medicine, New Haven, CT 06520,Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:40:43

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号